Apoptosis occurs in response to unrepaired DNA damage. Apoptosis protects against cancer because it avoids the possibility of a cell with DNA damage replicating past the site of damage and undergoing a carcinogenic mutation. Our primary hypothesis, based on preliminary evidence and to be tested directly, is that epithelial cells, in the normal-appearing colon of patients with, or at elevated risk of developing, colon cancer, are deficient in the protective apoptosis pathway. This apparent deficiency may result from habitual eating of high-fat foods, which promotes high levels of cytotoxic bile acids/salts in the colon. Bile acids/salts damage cells of the normal colonic epithelium, causing many to undergo apoptosis. Although, initially, the loss of damaged cells by apoptosis is beneficial, chronic loss of apoptosis-sensitive cells over 30 to 40 years may select for mutant cells that are deficient in the protective apoptosis pathway. We think that long term exposure to raised concentrations of cytotoxic bile acids leads to a population of mutant colonic epithelial cells resistant to induced apoptosis. Such cells, upon exposure to dietary carcinogens, experience DNA damage, but would be unable to undergo apoptosis to avoid carcinogenesis.
The specific aims of our proposal are (1) to determine if cultured colonic epithelial cells, initially able to undergo bile acid induced apoptosis, develop stable resistance to induction of apoptosis when grown from many generations in medium containing deoxycholate; (2) to determine in rats if specific chemopreventive agents, i.e. the anti-carcinogenic bile acid ursodeoxycholic acid and the non-steroidal anti-inflammatory drugs Sulindac sulfone and aspirin prevent the development of resistance to bile acid induced apoptosis in colon epithelial cells; (3) to determine whether persons with colon cancer, or at high risk for colon cancer, have colonic epithelial cells resistant to deoxycholate induced apoptosis. Elucidation of the role of bile acid induced apoptosis, and the mechanism by which resistance to bile acid induced apoptosis develops, should give valuable insight into colon carcinogenesis. Furthermore, the measurement of resistance to bile acid induced apoptosis in colon biopsy specimens offers substantial promise as an early biomarker for colon cancer risk.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA072008-03S3
Application #
6340772
Study Section
Project Start
1999-07-01
Project End
2000-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$130,479
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Raj, K P; Zell, J A; Rock, C L et al. (2013) Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Br J Cancer 108:512-8
Rial, Nathaniel S; Zell, Jason A; Cohen, Alfred M et al. (2012) Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer. Expert Rev Gastroenterol Hepatol 6:507-17
Laukaitis, Christina M; Erdman, Steven H; Gerner, Eugene W (2012) Chemoprevention in patients with genetic risk of colorectal cancers. Colorectal Cancer 1:225-240
Laukaitis, Christina M; Gerner, Eugene W (2011) DFMO: targeted risk reduction therapy for colorectal neoplasia. Best Pract Res Clin Gastroenterol 25:495-506
Zell, Jason A; Ziogas, Argyrios; Ignatenko, Natalia et al. (2009) Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival. Clin Cancer Res 15:6208-16
Feldman, Rebecca; Martinez, Jesse D (2009) Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR. Biochim Biophys Acta 1793:1387-94
Gerner, Eugene W; Meyskens Jr, Frank L (2009) Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res 15:758-61
Rial, Nathaniel S; Lazennec, Gwendal; Prasad, Anil R et al. (2009) Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer. Int J Cancer 124:2270-80
Zell, Jason A; Pelot, Daniel; Chen, Wen-Pin et al. (2009) Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas. Cancer Prev Res (Phila) 2:209-12
Ashbeck, Erin L; Jacobs, Elizabeth T; Martínez, María Elena et al. (2009) Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 18:1134-43

Showing the most recent 10 out of 88 publications